Influence of Alfacalcidol on Falls in Elderly Postmenopausal Alendronate-Treated Osteopenic/Osteoporotic Women With High Risk of Falls
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Alfacalcidol (Primary) ; Alendronic acid
- Indications Bone resorption; Postmenopausal osteoporosis
- Focus Pharmacodynamics; Therapeutic Use
- Acronyms ALFA
- 11 May 2008 Status changed from in progress to completed, as reported by ClinicalTrials.gov.
- 09 May 2008 Biomarkers information updated
- 01 May 2008 The expected completion date for this trial is now May 2008 (Jul 2007 for final data collection date for primary outcome measure) according to ClinicalTrials.gov